<DOC>
	<DOCNO>NCT01967407</DOCNO>
	<brief_summary>The aim study evaluation ablation efficiency percutaneous irreversible electroporation ( IRE ) primary ablation therapy locally confine renal cell carcinoma ( ≤4cm , see inclusion exclusion criterion ) . The ablation success proof magnet resonance imaging ( MRI ) histologically partial kidney resection nephrectomy 4 week IRE . Hypotheses : Kidney tumor ≤4cm ablate completely percutaneous IRE . Surrounded structure renal tissue preserve .</brief_summary>
	<brief_title>IReversible Electroporation Kidney Tumors Before Partial Nephrectomy .</brief_title>
	<detailed_description>Health Condition Problem study : 1. International Statistical Classification Diseases Related Health Problems , Tenth Revision ( ICD10 ) : C64 - Malignant neoplasm kidney , except renal pelvis 2 . ICD10 : D41.0 - Neoplasm uncertain unknown behaviour : Kidney Interventions/Observational Groups Arm 1 : 1 . Initial diagnostical examination renal mass . 2 . If extend diagnostical examination treatment planning . 3 . Day -29 -1 : Recruitment . 4 . Day -1 : MRI kidney , Karnofsky , physical examination , blood chemistry , urosonography , renal scintigraphy , life quality assessment . 5 . Day 0 : Percutaneous diagnostical biopsy histopathological investigation therapeutically , CT- and/or ultrasound-guided , ECG-synchronized irreversible electroporation ( IRE ) kidney tumor endotracheal anaesthesia und muscle relaxation . Use 1-6 IRE probe 90-100 pulse 1500-3000 volt und 20-50 ampere . 6 . Day 1-7 : Postinterventional follow-up : MRI kidney , Karnofsky , physical examination , blood chemistry , urosonography , life quality assessment . 7 . Day 27 : Postinterventional follow-up : MRI kidney , Karnofsky , physical examination , blood chemistry , urosonography , renal scintigraphy , life quality assessment . 8 . Day 28 : Open surgery partial kidney resection tumor nephrectomy IRE treat kidney resp . kidney tumor region histopathological investigation . 9 . Day 29-37 : Postoperative follow-up : physical examination , blood chemistry , urosonography , life quality assessment . 10 . Day 112 : Study-Follow-up : MRI kidney , Karnofsky , physical examination , blood chemistry , urosonography , renal scintigraphy , life quality assessment . Termination study . 11 . Study close , Individual follow-up due European Association Urology guideline . Recruitment : - ( Anticipated Actual ) Date First Enrollment : 2013/10/14 - Planned/Actual : Opened - Target Sample Size : 20 - Monocentric/Multicentric trial : Monocentric trial - National/International : National</detailed_description>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<criteria>one localize , resectable kidney tumor ( ≤4 cm ) suspicious malignancy histology proven renal cell cancer ( RCC ) patient desire therapy surgical therapy Karnofskyindex &gt; 70 % Age ≥ 18 year life expectancy ≥ 12 month compliance patient take part study inform consent violation one inclusion criterion cardial pacemaker electrical implant QTinterval &gt; 550 m cardiac arrhythmia condition myocardial infarction , make ECGsynchronisation unfeasible know cardial ejection fraction &lt; 30 % NYHA III IIIIV know epilepsy second malignancy ( except basalcell carcinoma cervical carcinoma situ ) immunosuppression HIVpositive patient active infection severe health interference , make take part study unfeasible pregnancy , lactation period , contraception metastatic disease palliative status run execute RCC therapy take part another clinical study RCC inoperable rejection interventional surgical therapy patient circulatory instability general contraindication anesthesia , endotracheal anesthesia muscle relaxation psychiatric disorder make take part study give informed consent unfeasible haemorrhage , impossible intermission take blood thinner , untreatable thrombophilia thromboplastin time ≤50 % , thrombocytes ≤50 Gpt/L ; partial thromboplastin time &gt; 50 MRI incompatibility metal implant &lt; 1 cm close kidney / kidney tumor contraindication biopsy punction renal tumor CTguidance untreated urinary retention renal pelvis tumor , suspect transitional cell cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>kidney tumor</keyword>
	<keyword>renal cell cancer</keyword>
	<keyword>RCC</keyword>
	<keyword>irreversible electroporation</keyword>
	<keyword>IRE</keyword>
	<keyword>partial kidney resection</keyword>
	<keyword>percutaneous</keyword>
	<keyword>ablation</keyword>
	<keyword>IRENE</keyword>
</DOC>